Company Number: 14109725

Analysis Date: 2025-07-20 12:23 UTC

Certainly, let's conduct a comprehensive financial health assessment for MARCH GROCERY LTD, focusing on the latest available data as at 31 May 2024.

---

1. Financial Health Score: D

Explanation:
The company shows signs of financial strain, notably with negative net current assets (working capital deficit) and declining shareholder equity. These symptoms suggest liquidity challenges and potential difficulties in meeting short-term obligations without additional financing or operational improvements.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Current Assets	4,236	5,036	Decreasing current assets, mainly due to cash drop
Cash at Bank & In Hand	332	1,795	Sharp decline in cash reserves – weak liquidity
Debtors	0	56	Decline to zero; could impact future cash flow
Current Liabilities	6,013	6,295	Slightly reduced but still high relative to assets
Net Current Assets	-1,777	-1,259	Negative and worsening working capital – red flag
Fixed Assets (Plant & Machinery)	2,263	2,515	Slight depreciation but relatively stable
Shareholders’ Funds	486	1,256	Declined by over 60% indicating erosion of equity

Additional Observations:

• Stock Levels: Around £3,900 in stocks, increased from £3,185, which could tie up cash and affect liquidity.
• Trade Creditors: Approximately £1,630, a moderate level of supplier obligations.
• Other Creditors: Significant at £4,579, contributing to current liabilities pressure.
• No debts reported (bank loans or overdrafts) at year-end, which is positive but also means no external liquidity buffer.

---

3. Diagnosis: Financial Condition Assessment

Liquidity "Vital Signs":
MARCH GROCERY LTD is exhibiting symptoms of liquidity stress. The working capital is negative and worsening, which means the company’s short-term assets are insufficient to cover its short-term liabilities. A healthy "cash flow pulse" is weak, indicated by a significant drop in cash reserves from £1,795 to £332. This is akin to a patient whose blood pressure is dropping, signaling potential crisis if not addressed.

Profitability & Capital "Symptoms":
While profit and loss figures are not disclosed fully, the marked reduction in shareholders’ funds (equity) from £1,256 to £486 signals accumulated losses or capital consumption. This erosion indicates that the business is currently unable to generate sufficient profits or is incurring losses, weakening the financial "immune system."

Asset Management:
The company holds a relatively stable level of fixed assets but has increased stock levels, which may be contributing to cash flow strain if inventories are not turning over quickly.

Governance and Control:
The company is actively managed with a single controlling shareholder owning 75-100% of shares and voting rights, which can be advantageous for swift decision-making but may also concentrate financial risk.

---

4. Recommendations to Improve Financial Wellness

• Improve Cash Flow Management:
  Inject working capital or arrange short-term financing to strengthen liquidity and prevent payment delays. Like administering IV fluids to a dehydrated patient, cash injections can stabilize the company's financial condition.

• Reduce Inventory Levels:
  Aim to convert stock into sales more rapidly to free up cash. Excess stock is like excess weight that strains the system; trimming it down can improve operational efficiency.

• Cost Control and Profitability Focus:
  Conduct a detailed review of cost structures and pricing strategies to halt equity erosion and return to profitability. Think of this as a dietary plan to restore health by eliminating unnecessary expenditures.

• Strengthen Debtor Management:
  Although debtors are currently minimal, ensuring prompt payments from customers will prevent future liquidity shortages.

• Monitor and Manage Creditors:
  Negotiate better payment terms with suppliers to ease short-term cash outflows, similar to adjusting medication dosages to improve patient tolerance.

• Consider External Advisory:
  Engage financial advisors or turnaround specialists to diagnose underlying operational inefficiencies and implement strategic improvements.

---